Apogee Therapeutics (APGE) Other Non-Current Assets (2023 - 2026)

Apogee Therapeutics (APGE) has 4 years of Other Non-Current Assets data on file, last reported at $8.5 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 16.04% year-over-year to $8.5 million in Q1 2026; TTM through Mar 2026 was $8.5 million, a 16.04% increase from a year earlier, with the FY2025 full-year figure at $8.7 million, up 1641.16% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $8.5 million, down from $8.7 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for APGE reached as high as $8.9 million in Q2 2025 and fell as low as $401000.0 in Q4 2023.
• Historically, Other Non-Current Assets has averaged $4.4 million across 4 years, with a median of $3.9 million in 2024.
• Across the five-year window, Other Non-Current Assets jumped 1792.52% in 2025 and rose 16.04% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $401000.0 in 2023, then advanced by 24.19% to $498000.0 in 2024, then soared by 1641.16% to $8.7 million in 2025, then fell by 1.79% to $8.5 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $8.5 million in Q1 2026, $8.7 million in Q4 2025, and $8.7 million in Q3 2025.